Literature DB >> 31738422

A Network Analysis of Epigenetic and Transcriptional Regulation in a Neurodevelopmental Rat Model of Schizophrenia With Implications for Translational Research.

Yang Du1, Xue-Song Li2, Lei Chen1, Guang-Yang Chen2, Yong Cheng1,3.   

Abstract

Prenatal administration of mitotoxin methylazoxymethanol acetate (MAM) in rats produces behavioral, pharmacological, and anatomical abnormalities once offspring reach adulthood, thus establishing a widely used neurodevelopmental model of schizophrenia. However, the molecular aspects underlying this disease model are not well understood. Therefore, this study examines epigenetic and transcriptional dysregulation in the prefrontal cortex and hippocampus of MAM rats as these are brain regions closely associated with schizophrenia pathogenesis. Upon sequencing messenger and microRNA (mRNA and miRNA, respectively), differential expression was revealed in the prefrontal cortex and hippocampus between MAM- and saline-treated rats; sequencing data were validated by qualitative real-time polymerase chain reaction. Bioinformatic analyses demonstrated that the differentially expressed (DE) genes were strongly enriched in interactive pathways related to schizophrenia, including chemical synaptic transmission, cognition, and inflammatory responses; also, the potential target genes of the DE miRNAs were enriched in pathways related to synapses and inflammation. The blood of schizophrenia patients and healthy controls was further analyzed for several top DE mRNAs: DOPA decarboxylase, ret proto-oncogene, Fc receptor-like 2, interferon lambda receptor 1, and myxovirus (influenza virus) resistance 2. The results demonstrated that the expression of these genes was dysregulated in patients with schizophrenia; combining these mRNAs sufficiently differentiated schizophrenia patients from controls. Taken together, this study suggests that the MAM model has the potential to reproduce hippocampus and prefrontal cortex abnormalities, relevant to schizophrenia, at the epigenetic and transcriptional levels. These data also provide novel targets for schizophrenia diagnoses and treatments.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  hippocampus; mRNA; methylazoxymethanol acetate; miRNA; prefrontal cortex

Mesh:

Substances:

Year:  2020        PMID: 31738422      PMCID: PMC7147587          DOI: 10.1093/schbul/sbz114

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  30 in total

Review 1.  In vivo imaging of neuroinflammation in schizophrenia.

Authors:  Ofer Pasternak; Marek Kubicki; Martha E Shenton
Journal:  Schizophr Res       Date:  2015-06-03       Impact factor: 4.939

2.  Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer.

Authors:  Jiangyong Yu; Shuhang Wang; Wei Zhao; Jianchun Duan; Zhijie Wang; Hanxiao Chen; Yanhua Tian; Di Wang; Jun Zhao; Tongtong An; Hua Bai; Meina Wu; Jie Wang
Journal:  Clin Cancer Res       Date:  2018-02-06       Impact factor: 12.531

3.  Elevated dopa decarboxylase activity in living brain of patients with psychosis.

Authors:  J Reith; C Benkelfat; A Sherwin; Y Yasuhara; H Kuwabara; F Andermann; S Bachneff; P Cumming; M Diksic; S E Dyve; P Etienne; A C Evans; S Lal; M Shevell; G Savard; D F Wong; G Chouinard; A Gjedde
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

4.  Genome-Wide, Integrative Analysis Implicates Exosome-Derived MicroRNA Dysregulation in Schizophrenia.

Authors:  Yang Du; Yun Yu; Yang Hu; Xiao-Wan Li; Ze-Xu Wei; Rui-Yuan Pan; Xue-Song Li; Guang-En Zheng; Xiao-Yan Qin; Qing-Shan Liu; Yong Cheng
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

Review 5.  New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy.

Authors:  Nikhil M Urs; Sean M Peterson; Marc G Caron
Journal:  Biol Psychiatry       Date:  2016-10-19       Impact factor: 13.382

6.  Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277).

Authors:  X-Y Qin; C Cao; N X Cawley; T-T Liu; J Yuan; Y P Loh; Y Cheng
Journal:  Mol Psychiatry       Date:  2016-04-26       Impact factor: 15.992

Review 7.  Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction.

Authors:  David W Volk; David A Lewis
Journal:  Physiol Behav       Date:  2002-12

8.  The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus.

Authors:  Eva Hradetzky; Thomas M Sanderson; Tsz M Tsang; John L Sherwood; Stephen M Fitzjohn; Viktor Lakics; Nadia Malik; Stephanie Schoeffmann; Michael J O'Neill; Tammy Mk Cheng; Laura W Harris; Hassan Rahmoune; Paul C Guest; Emanuele Sher; Graham L Collingridge; Elaine Holmes; Mark D Tricklebank; Sabine Bahn
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

9.  N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.

Authors:  Philippe Conus; Larry J Seidman; Margot Fournier; Lijing Xin; Martine Cleusix; Philipp S Baumann; Carina Ferrari; Ann Cousins; Luis Alameda; Mehdi Gholam-Rezaee; Philippe Golay; Raoul Jenni; T-U Wilson Woo; Matcheri S Keshavan; Chin B Eap; Joanne Wojcik; Michel Cuenod; Thierry Buclin; Rolf Gruetter; Kim Q Do
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

10.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

View more
  5 in total

1.  Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications.

Authors:  Lei Chen; Wen-Hui Zheng; Yang Du; Xue-Song Li; Yun Yu; Hua Wang; Yong Cheng
Journal:  Front Med (Lausanne)       Date:  2021-11-24

2.  Paeoniflorin Rescued MK-801-Induced Schizophrenia-Like Behaviors in Mice via Oxidative Stress Pathway.

Authors:  Jia-Quan Liang; Xi Chen; Yong Cheng
Journal:  Front Nutr       Date:  2022-04-27

3.  Metabolomic Identification of Serum Exosome-Derived Biomarkers for Bipolar Disorder.

Authors:  Yang Du; Ji-Hui Dong; Lei Chen; Hua Liu; Guang-En Zheng; Guang-Yang Chen; Yong Cheng
Journal:  Oxid Med Cell Longev       Date:  2022-01-10       Impact factor: 6.543

Review 4.  Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease.

Authors:  Glen E Kisby; Peter S Spencer
Journal:  Front Neurosci       Date:  2021-12-02       Impact factor: 4.677

Review 5.  Exploring concomitant neuroimaging and genetic alterations in patients with and patients without auditory verbal hallucinations: A pilot study and mini review.

Authors:  Haiping Yu; Wang Ying; Gang Li; Xiaodong Lin; Deguo Jiang; Guangdong Chen; Suling Chen; Xiuhai Sun; Yong Xu; Jiaen Ye; Chuanjun Zhuo
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.